Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Gross Profit (2016 - 2025)

Historic Gross Profit for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $5.6 million.

  • Utah Medical Products' Gross Profit fell 341.26% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year decrease of 1488.87%. This contributed to the annual value of $24.1 million for FY2024, which is 1962.51% down from last year.
  • Per Utah Medical Products' latest filing, its Gross Profit stood at $5.6 million for Q3 2025, which was down 341.26% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Gross Profit registered a high of $8.3 million during Q4 2022, and its lowest value of $5.3 million during Q4 2024.
  • Moreover, its 5-year median value for Gross Profit was $7.4 million (2023), whereas its average is $7.1 million.
  • In the last 5 years, Utah Medical Products' Gross Profit surged by 5727.27% in 2021 and then crashed by 2500.7% in 2024.
  • Over the past 5 years, Utah Medical Products' Gross Profit (Quarter) stood at $8.1 million in 2021, then grew by 2.65% to $8.3 million in 2022, then decreased by 14.76% to $7.1 million in 2023, then dropped by 25.01% to $5.3 million in 2024, then rose by 5.28% to $5.6 million in 2025.
  • Its Gross Profit was $5.6 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.5 million in Q1 2025.